Medicare Officially Limits Coverage of Aduhelm to Patients in Clinical Trials
The New York Times
Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.
More Related News
Officials cited data showing the new Alzheimer’s drug has serious safety risks and may not help patients.